{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:19:14Z","timestamp":1787008754486,"version":"build-2736575974"},"reference-count":80,"publisher":"Oxford University Press (OUP)","issue":"19","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Heart failure with reduced or preserved ejection fraction is associated with elevated left atrial pressure at rest due to fluid overload or during exercise, leading to pulmonary venous congestion. Even with available treatments, heart failure hospitalizations remain high, and improvements in quality-of-life scores and functional capacity are modest. Thus, there is growing interest in non-pharmacological methods to decompress the left atrium and improve heart failure symptoms and outcomes. Left-to-right shunts have emerged as a potential therapeutic option to reduce left atrial hypertension, improve quality of life, and impact long-term outcomes. This nascent field carries both potential therapeutic promise and many unanswered questions. Recent data have questioned whether the effects of this therapy vary based on the left ventricular ejection fraction, pulmonary vascular resistance, and\/or right ventricular structure and function. This review discusses the basis for left-to-right shunt therapies, synthesizes past and ongoing clinical trials, and offers future directions.<\/jats:p>","DOI":"10.1093\/eurheartj\/ehaf120","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T15:22:25Z","timestamp":1739287345000},"page":"1787-1802","source":"Crossref","is-referenced-by-count":8,"title":["Therapeutic left-to-right shunting in heart failure"],"prefix":"10.1093","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7174-8604","authenticated-orcid":false,"given":"Francesco","family":"Fioretti","sequence":"first","affiliation":[{"name":"Baylor Scott & White Research Institute , 3434 Live Oak St., Dallas, TX 75204 ,","place":["USA"]},{"name":"Cardiology Unit, ASST Spedali Civili Hospital and University of Brescia , Brescia ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3755-4985","authenticated-orcid":false,"given":"Ajith P","family":"Nair","sequence":"additional","affiliation":[{"name":"Section of Cardiology, Baylor College of Medicine , Houston, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0805-8683","authenticated-orcid":false,"given":"Stefan D","family":"Anker","sequence":"additional","affiliation":[{"name":"Department of Cardiology (CVK) of German Heart Center Charit\u00e9, Charit\u00e9 Universit\u00e4tsmedizin , Berlin ,","place":["Germany"]},{"name":"German Centre for Cardiovascular Research (DZHK) Partner Site Berlin, Charit\u00e9 Universit\u00e4tsmedizin , Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9375-0596","authenticated-orcid":false,"given":"Barry A","family":"Borlaug","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic , Rochester, MN ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1086-127X","authenticated-orcid":false,"given":"Dean J","family":"Kereiakes","sequence":"additional","affiliation":[{"name":"The Christ Hospital Heart & Vascular Institute and The Carl and Edyth Lindner Center for Research and Education, Cincinnati, OH ,","place":["USA"]},{"name":"The Ohio State University , Columbus, OH ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9207-3634","authenticated-orcid":false,"given":"JoAnn","family":"Lindenfeld","sequence":"additional","affiliation":[{"name":"Vanderbilt Heart and Vascular Institute, Vanderbilt University Medical Center , Nashville, TN ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3416-8210","authenticated-orcid":false,"given":"Gregg W","family":"Stone","sequence":"additional","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai , New York, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4267-6933","authenticated-orcid":false,"given":"Javed","family":"Butler","sequence":"additional","affiliation":[{"name":"Baylor Scott & White Research Institute , 3434 Live Oak St., Dallas, TX 75204 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"key":"2025052711420111500_ehaf120-B1","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators","year":"2018","journal-title":"Lancet"},{"key":"2025052711420111500_ehaf120-B2","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"2025052711420111500_ehaf120-B3","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1093\/eurheartj\/ehy268","article-title":"Haemodynamics, dyspnoea, and pulmonary reserve in heart failure with preserved ejection fraction","volume":"39","author":"Obokata","year":"2018","journal-title":"Eur Heart J"},{"key":"2025052711420111500_ehaf120-B4","doi-asserted-by":"publisher","first-page":"3721","DOI":"10.1093\/eurheartj\/ehz713","article-title":"The haemodynamic basis of lung congestion during exercise in heart failure with preserved ejection fraction","volume":"40","author":"Reddy","year":"2019","journal-title":"Eur Heart J"},{"key":"2025052711420111500_ehaf120-B5","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1161\/CIRCULATIONAHA.108.783910","article-title":"Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures","volume":"118","author":"Zile","year":"2008","journal-title":"Circulation"},{"key":"2025052711420111500_ehaf120-B6","doi-asserted-by":"publisher","first-page":"15146","DOI":"10.3390\/ijms150915146","article-title":"The three integrated phases of left atrial macrophysiology and their interactions","volume":"15","author":"Mehrzad","year":"2014","journal-title":"Int J Mol Sci"},{"key":"2025052711420111500_ehaf120-B7","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.jacbts.2019.05.005","article-title":"Atrial myopathy","volume":"4","author":"Shen","year":"2019","journal-title":"JACC Basic Transl Sci"},{"key":"2025052711420111500_ehaf120-B8","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.jacc.2020.07.009","article-title":"Atrial dysfunction in patients with heart failure with preserved ejection fraction and atrial fibrillation","volume":"76","author":"Reddy","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2025052711420111500_ehaf120-B9","doi-asserted-by":"publisher","first-page":"e005467","DOI":"10.1161\/CIRCIMAGING.116.005467","article-title":"Influence of left atrial function on exercise capacity and left ventricular function in patients with heart failure and preserved ejection fraction","volume":"10","author":"von Roeder","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"2025052711420111500_ehaf120-B10","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/ejhf.1643","article-title":"Left atrial function in heart failure with preserved ejection fraction: a systematic review and meta-analysis","volume":"22","author":"Khan","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2025052711420111500_ehaf120-B11","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1093\/eurheartj\/ehac184","article-title":"Pulmonary vascular disease in pulmonary hypertension due to left heart disease: pathophysiologic implications","volume":"43","author":"Omote","year":"2022","journal-title":"Eur Heart J"},{"key":"2025052711420111500_ehaf120-B12","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1093\/eurheartj\/ehy331","article-title":"Exercise unmasks distinct pathophysiologic features in heart failure with preserved ejection fraction and pulmonary vascular disease","volume":"39","author":"Gorter","year":"2018","journal-title":"Eur Heart J"},{"key":"2025052711420111500_ehaf120-B13","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jacc.2023.05.010","article-title":"Right ventricular function and pulmonary coupling in patients with heart failure and preserved ejection fraction","volume":"82","author":"Inciardi","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2025052711420111500_ehaf120-B14","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1002\/ehf2.13386","article-title":"Predictors and prognosis of right ventricular function in pulmonary hypertension due to heart failure with reduced ejection fraction","volume":"8","author":"Schmei\u00dfer","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2025052711420111500_ehaf120-B15","doi-asserted-by":"publisher","first-page":"e004121","DOI":"10.1161\/CIRCHEARTFAILURE.117.004121","article-title":"Load-independent systolic and diastolic right ventricular function in heart failure with preserved ejection fraction as assessed by resting and handgrip exercise pressure-volume loops","volume":"11","author":"Rommel","year":"2018","journal-title":"Circ Heart Fail"},{"key":"2025052711420111500_ehaf120-B16","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.1093\/eurheartj\/ehw241","article-title":"Abnormal right ventricular-pulmonary artery coupling with exercise in heart failure with preserved ejection fraction","volume":"37","author":"Borlaug","year":"2016","journal-title":"Eur Heart J"},{"key":"2025052711420111500_ehaf120-B17","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.cjco.2022.07.014","article-title":"Right ventricular dimension for heart failure with preserved ejection fraction involving right ventricular-vascular uncoupling","volume":"4","author":"Nakagawa","year":"2022","journal-title":"CJC Open"},{"key":"2025052711420111500_ehaf120-B18","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.jcin.2021.07.047","article-title":"Right ventricular-pulmonary arterial coupling in patients with HF secondary MR: analysis from the COAPT trial","volume":"14","author":"Brener","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"2025052711420111500_ehaf120-B19","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.jcmg.2016.09.021","article-title":"Left atrial function dynamics during exercise in heart failure: pathophysiological implications on the right heart and exercise ventilation inefficiency","volume":"10","author":"Sugimoto","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025052711420111500_ehaf120-B20","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1001\/jamacardio.2024.1914","article-title":"Dapagliflozin and right ventricular-pulmonary vascular interaction in heart failure with preserved ejection fraction: a secondary analysis of a randomized clinical trial","volume":"9","author":"Reddy","year":"2024","journal-title":"JAMA Cardiol"},{"key":"2025052711420111500_ehaf120-B21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s10741-022-10236-8","article-title":"Device therapy with interatrial shunt devices for heart failure with preserved ejection fraction","volume":"28","author":"Nanayakkara","year":"2023","journal-title":"Heart Fail Rev"},{"key":"2025052711420111500_ehaf120-B22","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/S0140-6736(16)00704-2","article-title":"A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, Phase 1 trial","volume":"387","author":"Hasenfuss","year":"2016","journal-title":"Lancet"},{"key":"2025052711420111500_ehaf120-B23","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1093\/cvr\/cvac120","article-title":"Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets","volume":"118","author":"Borlaug","year":"2023","journal-title":"Cardiovasc Res"},{"key":"2025052711420111500_ehaf120-B24","volume-title":"StatPearls","author":"Mahajan","year":"2024"},{"key":"2025052711420111500_ehaf120-B25","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.cardfail.2014.01.005","article-title":"Effects of an interatrial shunt on rest and exercise hemodynamics: results of a computer simulation in heart failure","volume":"20","author":"Kaye","year":"2014","journal-title":"J Card Fail"},{"key":"2025052711420111500_ehaf120-B26","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1016\/j.jacc.2019.08.1062","article-title":"Effects of interatrial shunt on pulmonary vascular function in heart failure with preserved ejection fraction","volume":"74","author":"Obokata","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2025052711420111500_ehaf120-B27","doi-asserted-by":"publisher","first-page":"100090","DOI":"10.1016\/j.shj.2022.100090","article-title":"Update on atrial shunt therapy for treatment of heart failure","volume":"6","author":"Litwin","year":"2022","journal-title":"Struct Heart"},{"key":"2025052711420111500_ehaf120-B28","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1161\/CIRCULATIONAHA.117.032094","article-title":"Transcatheter interatrial shunt device for the treatment of heart failure with preserved ejection fraction (REDUCE LAP-HF I [reduce elevated left atrial pressure in patients with heart failure]): a Phase 2, randomized, sham-controlled trial","volume":"137","author":"Feldman","year":"2018","journal-title":"Circulation"},{"key":"2025052711420111500_ehaf120-B29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3389\/fcvm.2019.00075","article-title":"Antithrombotic\/antiplatelet treatment in transcatheter structural cardiac interventions-PFO\/ASD\/LAA occluder and interatrial shunt devices","volume":"6","author":"Olasinska-Wisniewska","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"2025052711420111500_ehaf120-B30","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/ejhf.111","article-title":"Transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction using a novel interatrial implant to lower left atrial pressure","volume":"16","author":"Sondergaard","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2025052711420111500_ehaf120-B31","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.cardfail.2015.05.008","article-title":"Rationale and design of the reduce elevated left atrial pressure in patients with heart failure (reduce LAP-HF) trial","volume":"21","author":"Hasenfuss","year":"2015","journal-title":"J Card Fail"},{"key":"2025052711420111500_ehaf120-B32","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ijcard.2015.03.198","article-title":"Clinical outcome of transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction using a novel implant","volume":"187","author":"Malek","year":"2015","journal-title":"Int J Cardiol"},{"key":"2025052711420111500_ehaf120-B33","doi-asserted-by":"publisher","first-page":"e003662","DOI":"10.1161\/CIRCHEARTFAILURE.116.003662","article-title":"One-year outcomes after transcatheter insertion of an interatrial shunt device for the management of heart failure with preserved ejection fraction","volume":"9","author":"Kaye","year":"2016","journal-title":"Circ Heart Fail"},{"key":"2025052711420111500_ehaf120-B34","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1001\/jamacardio.2018.2936","article-title":"One-year safety and clinical outcomes of a transcatheter interatrial shunt device for the treatment of heart failure with preserved ejection fraction in the reduce elevated left atrial pressure in patients with heart failure (REDUCE LAP-HF I) trial: a randomized clinical trial","volume":"3","author":"Shah","year":"2018","journal-title":"JAMA Cardiol"},{"key":"2025052711420111500_ehaf120-B35","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/S0140-6736(22)00016-2","article-title":"Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial","volume":"399","author":"Shah","year":"2022","journal-title":"Lancet"},{"key":"2025052711420111500_ehaf120-B36","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1161\/CIRCULATIONAHA.122.059486","article-title":"Latent pulmonary vascular disease may alter the response to therapeutic atrial shunt device in heart failure","volume":"145","author":"Borlaug","year":"2022","journal-title":"Circulation"},{"key":"2025052711420111500_ehaf120-B37","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.jchf.2023.01.030","article-title":"Exercise-induced left atrial hypertension in heart failure with preserved ejection fraction","volume":"11","author":"Litwin","year":"2023","journal-title":"JACC Heart Fail"},{"key":"2025052711420111500_ehaf120-B38","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.jchf.2024.04.011","article-title":"2-year outcomes of an atrial shunt device in HFpEF\/HFmrEF: results from REDUCE LAP-HF II","volume":"12","author":"Gustafsson","year":"2024","journal-title":"JACC Heart Fail"},{"key":"2025052711420111500_ehaf120-B39","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/S0140-6736(16)00585-7","article-title":"Unidirectional left-to-right interatrial shunting for treatment of patients with heart failure with reduced ejection fraction: a safety and proof-of-principle cohort study","volume":"387","author":"Del Trigo","year":"2016","journal-title":"Lancet"},{"key":"2025052711420111500_ehaf120-B40","doi-asserted-by":"publisher","first-page":"164","DOI":"10.4244\/EIJ-D-18-01211","article-title":"Interatrial shunting for heart failure: current evidence and future perspectives","volume":"15","author":"Guimaraes","year":"2019","journal-title":"EuroIntervention"},{"key":"2025052711420111500_ehaf120-B41","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.4244\/EIJY14M05_07","article-title":"Left atrial decompression through unidirectional left-to-right interatrial shunt for the treatment of left heart failure: first-in-man experience with the V-wave device","volume":"10","author":"Amat-Santos","year":"2015","journal-title":"EuroIntervention"},{"key":"2025052711420111500_ehaf120-B42","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1016\/j.jcin.2018.07.001","article-title":"Interatrial shunting for heart failure: early and late results from the first-in-human experience with the V-Wave system","volume":"11","author":"Rodes-Cabau","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"2025052711420111500_ehaf120-B43","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/ejhf.3215","article-title":"Interatrial shunt therapy in advanced heart failure: outcomes from the open-label cohort of the RELIEVE-HF trial","volume":"26","author":"Rodes-Cabau","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2025052711420111500_ehaf120-B44","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1161\/CIRCULATIONAHA.124.070870","article-title":"Interatrial shunt treatment for heart failure: the randomized RELIEVE-HF trial","volume":"150","author":"Stone","year":"2024","journal-title":"Circulation"},{"key":"2025052711420111500_ehaf120-B45","doi-asserted-by":"publisher","first-page":"403","DOI":"10.4244\/EIJ-D-19-00342","article-title":"The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction","volume":"15","author":"Paitazoglou","year":"2019","journal-title":"EuroIntervention"},{"key":"2025052711420111500_ehaf120-B46","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1002\/ejhf.2119","article-title":"One-year results of the first-in-man study investigating the Atrial Flow Regulator for left atrial shunting in symptomatic heart failure patients: the PRELIEVE study","volume":"23","author":"Paitazoglou","year":"2021","journal-title":"Eur J Heart Fail"},{"issue":":","key":"2025052711420111500_ehaf120-B47","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.jchf.2023.01.024","article-title":"No-implant interatrial shunt for HFpEF: six-month outcomes from multicenter pilot feasibility studies","volume":"11","author":"Udelson","year":"2023","journal-title":"JACC Heart Fail"},{"key":"2025052711420111500_ehaf120-B48"},{"key":"2025052711420111500_ehaf120-B49","doi-asserted-by":"publisher","first-page":"e008362","DOI":"10.1161\/CIRCHEARTFAILURE.121.008362","article-title":"The RAISE trial: a novel device and first-in-man trial","volume":"15","author":"Sun","year":"2022","journal-title":"Circ Heart Fail"},{"key":"2025052711420111500_ehaf120-B50"},{"key":"2025052711420111500_ehaf120-B51","doi-asserted-by":"publisher","first-page":"B139","DOI":"10.1016\/j.jacc.2022.08.403","article-title":"TCT-343 evaluation of an implant free interatrial shunt to improve heart failure: EASE HF","volume":"80","author":"Vardi","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2025052711420111500_ehaf120-B52","doi-asserted-by":"publisher","first-page":"101203","DOI":"10.1016\/j.jscai.2023.101203","article-title":"Atrial shunt therapy for heart failure: an update","volume":"2","author":"Jagadeesan","year":"2023","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"2025052711420111500_ehaf120-B53"},{"key":"2025052711420111500_ehaf120-B54"},{"key":"2025052711420111500_ehaf120-B55","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1002\/ehf2.13842","article-title":"Clinical study on the treatment of chronic heart failure with a novel D-shant atrium shunt device","volume":"9","author":"Shang","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2025052711420111500_ehaf120-B56","doi-asserted-by":"publisher","first-page":"1121689","DOI":"10.3389\/fcvm.2023.1121689","article-title":"Biventricular longitudinal strain as a predictor of functional improvement after D-shant device implantation in patients with heart failure","volume":"10","author":"Zhou","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"2025052711420111500_ehaf120-B57"},{"key":"2025052711420111500_ehaf120-B58","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.jcin.2020.02.022","article-title":"Percutaneous atriotomy for levoatrial\u2013to\u2013coronary sinus shunting in symptomatic heart failure","volume":"13","author":"Simard","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"2025052711420111500_ehaf120-B59","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1002\/jmri.25457","article-title":"Quantifying right atrial filling and emptying: a 4D-flow MRI study","volume":"45","author":"Callaghan","year":"2017","journal-title":"J Magn Reson Imaging"},{"key":"2025052711420111500_ehaf120-B60","doi-asserted-by":"publisher","first-page":"H2344","DOI":"10.1152\/ajpheart.00622.2011","article-title":"4-D blood flow in the human right ventricle","volume":"301","author":"Fredriksson","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2025052711420111500_ehaf120-B61","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.jcin.2023.04.014","article-title":"A different path to relief?: the left atrium to coronary sinus shunt for heart failure","volume":"16","author":"Borlaug","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"2025052711420111500_ehaf120-B62","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1056\/NEJMoa1402556","article-title":"Efficacy of a device to narrow the coronary sinus in refractory angina","volume":"372","author":"Verheye","year":"2015","journal-title":"N Engl J Med"},{"key":"2025052711420111500_ehaf120-B63","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jamacardio.2023.2566","article-title":"Coronary venous pressure and microvascular hemodynamics in patients with microvascular angina: a randomized clinical trial","volume":"8","author":"Ullrich","year":"2023","journal-title":"JAMA Cardiol"},{"key":"2025052711420111500_ehaf120-B64","doi-asserted-by":"publisher","first-page":"H895","DOI":"10.1152\/ajpheart.00436.2019","article-title":"A murine model of increased coronary sinus pressure induces myocardial edema with cardiac lymphatic dilation and fibrosis","volume":"318","author":"Nielsen","year":"2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2025052711420111500_ehaf120-B65","doi-asserted-by":"publisher","first-page":"102039","DOI":"10.1016\/j.jaccas.2023.102039","article-title":"Late outcome of a left-atrial-to-coronary-sinus shunt","volume":"26","author":"Bassi","year":"2023","journal-title":"JACC Case Rep"},{"key":"2025052711420111500_ehaf120-B66","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.jcin.2023.03.012","article-title":"Left atrial to coronary sinus shunting for treatment of symptomatic heart failure","volume":"16","author":"Hibbert","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"2025052711420111500_ehaf120-B67","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1002\/ejhf.3241","article-title":"Left atrial to coronary sinus shunting for treatment of heart failure with mildly reduced or preserved ejection fraction: the ALT FLOW early feasibility study 1-year results","volume":"26","author":"Urey","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2025052711420111500_ehaf120-B68"},{"key":"2025052711420111500_ehaf120-B69","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s10741-024-10407-9","article-title":"Evaluating the role of interatrial shunt devices in heart failure management: insights from the RELIEVE-HF trial","volume":"29","author":"Sideris","year":"2024","journal-title":"Heart Fail Rev"},{"key":"2025052711420111500_ehaf120-B70","volume-title":"Heart Failure 2024","author":"Zile","year":"2024"},{"key":"2025052711420111500_ehaf120-B71","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/jamacardio.2024.0520","article-title":"Atrial shunt device effects on cardiac structure and function in heart failure with preserved ejection fraction: the REDUCE LAP-HF II randomized clinical trial","volume":"9","author":"Patel","year":"2024","journal-title":"JAMA Cardiol"},{"key":"2025052711420111500_ehaf120-B72","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/ejhf.2747","article-title":"Central haemodynamic abnormalities and outcome in patients with unexplained dyspnoea","volume":"25","author":"Omote","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2025052711420111500_ehaf120-B73","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1016\/j.jacc.2019.03.482","article-title":"Threshold of pulmonary hypertension associated with increased mortality","volume":"73","author":"Strange","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2025052711420111500_ehaf120-B74","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S2213-2600(20)30317-9","article-title":"Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study","volume":"8","author":"Maron","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2025052711420111500_ehaf120-B75","doi-asserted-by":"publisher","first-page":"e004436","DOI":"10.1161\/CIRCHEARTFAILURE.117.004436","article-title":"Pulmonary effective arterial elastance as a measure of right ventricular afterload and its prognostic value in pulmonary hypertension due to left heart disease","volume":"11","author":"Tampakakis","year":"2018","journal-title":"Circ Heart Fail"},{"key":"2025052711420111500_ehaf120-B76","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1164\/rccm.202211-2097OC","article-title":"Elevated pulmonary arterial compliance is associated with survival in pulmonary hypertension: results from a novel network medicine analysis","volume":"208","author":"Wang","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2025052711420111500_ehaf120-B77","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1001\/jamacardio.2018.0128","article-title":"Association between hemodynamic markers of pulmonary hypertension and outcomes in heart failure with preserved ejection fraction","volume":"3","author":"Vanderpool","year":"2018","journal-title":"JAMA Cardiol"},{"key":"2025052711420111500_ehaf120-B78","doi-asserted-by":"publisher","first-page":"035007","DOI":"10.1088\/1361-6579\/ab7d77","article-title":"The role of flow rotation in the adult right atrium: a 4D flow cardiovascular magnetic resonance study","volume":"41","author":"Dewhurst","year":"2020","journal-title":"Physiol Meas"},{"key":"2025052711420111500_ehaf120-B79","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jcin.2020.10.032","article-title":"Biventricular physiology of iatrogenic atrial septal defects following transcatheter mitral valve edge-to-edge repair","volume":"14","author":"Blazek","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"2025052711420111500_ehaf120-B80","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1161\/CIRCULATIONAHA.120.051989","article-title":"Closure of iatrogenic atrial septal defect after transcatheter mitral valve repair: the randomized MITHRAS trial","volume":"143","author":"Lurz","year":"2021","journal-title":"Circulation"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article-pdf\/doi\/10.1093\/eurheartj\/ehaf120\/61865675\/ehaf120.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/46\/19\/1787\/61865675\/ehaf120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/46\/19\/1787\/61865675\/ehaf120.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T11:42:09Z","timestamp":1748346129000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/46\/19\/1787\/8010892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":80,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2025,2,13]]},"published-print":{"date-parts":[[2025,5,14]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehaf120","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5,14]]},"published":{"date-parts":[[2025,2,13]]}}}